556 related articles for article (PubMed ID: 16774108)
1. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
Lewis TG; Tuchinda C; Lim HW; Wong HK
J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
[TBL] [Abstract][Full Text] [Related]
2. Erythrodermic, recalcitrant psoriasis: clinical resolution with infliximab.
Rongioletti F; Borenstein M; Kirsner R; Kerdel F
J Dermatolog Treat; 2003 Dec; 14(4):222-5. PubMed ID: 14660268
[TBL] [Abstract][Full Text] [Related]
3. Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
Lisby S; Gniadecki R
Acta Derm Venereol; 2004; 84(3):247-8. PubMed ID: 15202853
[No Abstract] [Full Text] [Related]
4. Infliximab combined with methotrexate as long-term treatment for erythrodermic psoriasis.
Heikkilä H; Ranki A; Cajanus S; Karvonen SL
Arch Dermatol; 2005 Dec; 141(12):1607-10. PubMed ID: 16365275
[No Abstract] [Full Text] [Related]
5. Sustained efficacy of ustekinumab in refractory erythrodermic psoriasis after failure of antitumor necrosis factor therapies.
Castiñeiras I; Fernández-Diaz L; Juárez Y; Lueiro M
J Dermatol; 2012 Aug; 39(8):730-1. PubMed ID: 22364316
[No Abstract] [Full Text] [Related]
6. Long-term management of erythrodermic psoriasis with anti-TNF agents.
Romero-Maté A; García-Donoso C; Martinez-Morán C; Hernández-Núñez A; Borbujo J
Dermatol Online J; 2010 Jun; 16(6):15. PubMed ID: 20579470
[TBL] [Abstract][Full Text] [Related]
7. Erythrodermic psoriasis treated with ustekinumab: an Italian multicenter retrospective analysis.
Pescitelli L; Dini V; Gisondi P; Loconsole F; Piaserico S; Piccirillo A; Stinco G; Errichetti E; Talamonti M; Tripo L; Volpi W; Prignano F
J Dermatol Sci; 2015 May; 78(2):149-51. PubMed ID: 25681953
[No Abstract] [Full Text] [Related]
8. A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunity.
Poulalhon N; Begon E; Lebbé C; Lioté F; Lahfa M; Bengoufa D; Morel P; Dubertret L; Bachelez H
Br J Dermatol; 2007 Feb; 156(2):329-36. PubMed ID: 17223874
[TBL] [Abstract][Full Text] [Related]
9. Pustular and erythrodermic psoriasis.
Prystowsky JH; Cohen PR
Dermatol Clin; 1995 Oct; 13(4):757-70. PubMed ID: 8785881
[TBL] [Abstract][Full Text] [Related]
10. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recalcitrant pustular psoriasis with infliximab: effective reduction of chemokine expression.
Benoit S; Toksoy A; Bröcker EB; Gillitzer R; Goebeler M
Br J Dermatol; 2004 May; 150(5):1009-12. PubMed ID: 15149518
[TBL] [Abstract][Full Text] [Related]
12. Erythrodermic psoriasis successfully treated with efalizumab.
Piccirillo F; Stinco G; Patrone P
Eur J Dermatol; 2008; 18(3):357-8. PubMed ID: 18474483
[No Abstract] [Full Text] [Related]
13. [Our experience with infliximab in reclacitrant cases of psoriasis].
Pereiro M; González-Vilas D; Sánchez-Aguilar D; Toribio J
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():43-7. PubMed ID: 19080991
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pustular psoriasis with infliximab.
Weishaupt C; Metze D; Luger TA; Ständer S
J Dtsch Dermatol Ges; 2007 May; 5(5):397-9. PubMed ID: 17451384
[TBL] [Abstract][Full Text] [Related]
15. Pustular and erythrodermic psoriasis complicated by acute respiratory distress syndrome.
Sadeh JS; Rudikoff D; Gordon ML; Bowden J; Goldman BD; Lebwohl M
Arch Dermatol; 1997 Jun; 133(6):747-50. PubMed ID: 9197829
[TBL] [Abstract][Full Text] [Related]
16. Long-term remission induced by secukinumab in a 13-year-old boy having recalcitrant chronic erythrodermic psoriasis.
Dogra S; Bishnoi A; Narang T; Handa S
Dermatol Ther; 2018 Jul; 31(4):e12611. PubMed ID: 29687662
[No Abstract] [Full Text] [Related]
17. Efficacy of infliximab for severe recalcitrant psoriasis after 6 weeks of treatment.
DE Oliveira JP; Levy A; Morel P; Guibal F
J Dermatol; 2008 Sep; 35(9):575-80. PubMed ID: 18837702
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of treatment with infliximab in patients with moderate-severe psoriasis and high needs of therapy. A retrospective study of 43 patients].
Puig L
Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():30-5. PubMed ID: 19080989
[TBL] [Abstract][Full Text] [Related]
19. Infliximab monotherapy in psoriasis: a case of rapid clinical and histological response.
Vincek V; Jacob SE; Nassiri M; Herbert LM; Nadji M; Kerdel FA
Int J Dermatol; 2004 Apr; 43(4):303-8. PubMed ID: 15090021
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and safety of infliximab for 11 years in a patient with erythrodermic psoriasis and psoriatic arthritis.
Trídico LA; Antonio JR; Mathias CE; Pozetti EMO
An Bras Dermatol; 2017; 92(5):743-745. PubMed ID: 29166526
[No Abstract] [Full Text] [Related]
[Next] [New Search]
